Mounjaro 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DR26FQ93W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,244
Award facts
- Contract value 100% obligated
- $17,243.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a $17,243.61 delivery order for Mounjaro (tirzepatide) 7.5 mg/0.5 mL pens by the Defense Logistics Agency on November 3, 2025, with an ultimate completion date of November 4, 2025. This firm fixed-price, non-set-aside contract is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle serves as a comprehensive pharmaceutical support mechanism, enabling AmerisourceBergen to supply a wide range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military and federal healthcare systems globally.
AmerisourceBergen's contract portfolio with DLA demonstrates the company's established capability to meet federal medical procurement requirements through competitive award processes. As a major pharmaceutical distributor and healthcare solutions provider, the company supplies critical medications across multiple therapeutic domains, including diabetes treatments, neurological medications, pain management pharmaceuticals, and specialty products to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The competitively awarded delivery orders, which have ranged from minimal to substantial values, reflect the company's versatility and efficiency in fulfilling federal medical supply needs under firm fixed-price arrangements.
Quick answers
Who was awarded contract SPE2DR26FQ93W?
SPE2DR26FQ93W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DR26FQ93W worth?
The government has obligated $17,244 on SPE2DR26FQ93W.
Is contract SPE2DR26FQ93W an order under another contract?
Yes. SPE2DR26FQ93W is a delivery order under SPE2DR25D2003, an indefinite delivery contract.
Was contract SPE2DR26FQ93W competed?
The extent of competition for SPE2DR26FQ93W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award